PFM Health Sciences, LP - NEVRO CORP ownership

NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 25 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$16,341,500
+0.9%
17,500,0000.0%0.77%
+22.4%
Q2 2023$16,192,610
-1.6%
17,500,0000.0%0.63%
-13.5%
Q1 2023$16,450,000
+2.5%
17,500,0000.0%0.73%
+26.4%
Q4 2022$16,056,250
+88.5%
17,500,000
+94.4%
0.58%
+86.7%
Q3 2022$8,519,000
+144.8%
9,000,000
+350.0%
0.31%
+182.6%
Q2 2021$3,480,000
+14.8%
2,000,0000.0%0.11%
+17.2%
Q1 2021$3,032,000
-17.3%
2,000,0000.0%0.09%
-27.9%
Q4 2020$3,666,000
+16.3%
2,000,0000.0%0.13%
-11.6%
Q3 2020$3,151,000
+15.3%
2,000,0000.0%0.15%
+2.8%
Q2 2020$2,733,0002,000,0000.14%
Other shareholders
NEVRO CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Myriad Asset Management Ltd. 10,000,000$15,644,0003.40%
Perceptive Advisors 9,000,000$141,822,0002.07%
DeepCurrents Investment Group LLC 14,430,000$22,483,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 12,000,000$18,784,0000.46%
Polar Asset Management Partners Inc. 17,500,000$27,302,0000.37%
ZAZOVE ASSOCIATES LLC 1,320,000$2,063,0000.27%
WOLVERINE ASSET MANAGEMENT LLC 16,000,000$24,947,0000.22%
Context Capital Management, LLC 500,000$768,0000.17%
Context Partners Fund, L.P. 500,000$768,0000.17%
PFM Health Sciences, LP 2,000,000$3,151,0000.15%
View complete list of NEVRO CORP shareholders